Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor 15 (TCF15) is a basic helix-loop-helix (bHLH) transcription factor expressed in the nucleus, which requires dimerization with another bHLH protein for efficient DNA binding. TCF15 plays a critical role in early embryonic development, particularly in somitogenesis (segmentation of mesoderm into somites needed for skeletal muscle and vertebrae formation) and in the mesenchymal to epithelial transition during somite formation. TCF15 is also involved in regulating the transition of pluripotent stem cells toward somatic differentiation by repressing Nanog and upregulating Otx2, thereby priming embryonic stem cells for differentiation. Its activity is modulated by FGF signaling (which induces its expression) and Id proteins (which inhibit its function). TCF15 is not currently known to be a direct therapeutic target (such as a druggable receptor or enzyme), but it has been studied as a key developmental regulator and is associated with certain rare congenital disorders. If additional information is needed, consult primary sources on TCF15’s gene and protein function, such as UniProt, GeneCards, and NCBI Gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor 15 (TCF15).